allegro ophthalmics reports phase ii data for luminate
Published 7 years ago • 80 plays • Length 7:04Download video MP4
Download video MP3
Similar videos
-
4:24
allegro ophthalmics: first-in-class anti-integrin agent (ois@asrs 2016)
-
6:08
allegro ophthalmics preps for phase iii of risuteganib
-
5:42
allegro ophthalmics - innovation showcase at ophthalmology innovation summit @ asrs 2019
-
6:38
allegro ophthalmics
-
6:14
allegro ophthalmics - innovation showcase at ophthalmology innovation summit @ ascrs 2019
-
7:32
allegro ophthalmics - ois@aao 2015
-
6:39
allegro’s luminate achieves primary endpoint in dme trial (ois@aao 2016)
-
6:44
allegro ophthalmics - innovation showcase at ophthalmology innovation summit @ aao 2019
-
2:29
procap animation
-
6:25:08
ophthalmic ai summit 2024
-
2:39
fuchs' corneal dystrophy: 5 things to know
-
2:51
ophthalmology innovator stories: what is allegro ophthalmics?
-
7:03
almog aley-raz - corneat vision
-
39:44
ois podcast episode #310: ophthalmology innovation year in review final
-
8:52
why ophthalmology is ready for artificial intelligence
-
5:09
graybug moves forward on gb-102 ascending-dose trial
-
6:04
novaliq gmbh - innovation showcase at ophthalmology innovation summit @ ascrs 2019
-
4:14
ocular innovation
-
9:16
max ostermeier presents implandata ophthalmic products at lsi europe '23
-
6:35
stealth biotherapeutics' new approach to treating eye diseases
-
10:04
innovation in clinical trials – using ai in oct scans
-
7:20
neuromodtronic - innovation showcase at ophthalmology innovation summit @ aao 2019